Irrigation-aspiration catheter for local drug delivery without volume restrictions
Reference number | |
Coordinator | IRRAS AB |
Funding from Vinnova | SEK 1 629 239 |
Project duration | April 2013 - July 2015 |
Status | Completed |
Important results from the project
This project proposal has comprised the development of a novel drug delivery catheter with the ability to simultaneously aspirate and irrigate fluids from and into body cavities. The catheter provides an alternative to systemic treatments of cancerous and infectious diseases, removing severe adverse effects. During the project the technical development of the novel catheter was performed, an updated generation system incorporating the learnings form the clinic is in development. Clinical testing and validation of the whole system (including all components) has been initiated.
Expected long term effects
Projektet har producerat följande resultat, alla viktiga milstolpar mot en marknadslansering av den nya katetern: Validering av den kliniska nyttan av prototypen Färdigutvecklad kateter för användning i kliniska studier Genomförd klinisk pilotstudie Fortsatt arbete med IP skydd kring teknologin CE-Märkning
Approach and implementation
The project execution has followed the following structure: WP1 - Project management & quality assurance WP2 - Catheter development WP3 -Validation-pilot study WP4 - Clinical study The validation clinical testing has been completed and new necessary software and hardware changes have been identified. Solid progress in the implantation of those changes has been made resulting in updates to the system. Meanwhile discussions with the Rikshospitalet physician team to define the design of the clinical testing going forward have been initiated.